Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>cas 6112-76-1 99 % puriy 6-Mercaptopurine monohydrate powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

cas 6112-76-1 99 % puriy 6-Mercaptopurine monohydrate powder

CAS NO.6112-76-1

  • Min.Order: 10 Gram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • 6-Mercaptopurine monohydrate
  • 6-Mercaptopurine monohydrate powder
  • 99% 6-Mercaptopurine monohydrate

Quick Details

  • ProName: cas 6112-76-1 99 % puriy 6-Mercaptop...
  • CasNo: 6112-76-1
  • Molecular Formula: C14H4N2Na2O8
  • Appearance: white
  • Application: anti aging
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Month
  • Purity: 99
  • Storage: room
  • LimitNum: 10 Gram

Superiority

 cas 6112-76-1   99 % puriy 6-Mercaptopurine monohydrate  powder  

MOQ:

10g

Form:

Powder

Colour:

White

Test:

HPLC

Function:

anti cancer

Grade:

Pharm

 

Details

cas 6112-76-1   99 % puriy 6-Mercaptopurine monohydrate  powder  

Product Name:    6-Mercaptopurine monohydrate
CAS:    6112-76-1
MF:    C5H6N4OS
MW:    170.19
EINECS:    612-090-4

6-Mercaptopurine (6-MP) is an inhibitor of purine synthesis and interconversion. It is rapidly converted to 6-mercaptopurine ribonucleoside-5''-monophosphate, which inhibits phosphoribosyl pyrophosphate (PRPP) amidotransferase, the rate-limiting enzyme in purine synthesis. It also inhibits the conversion of IMP to adenylosuccinic acid and xanthylic acid and blocks AMP formation in vitro. 

6-MP inhibits growth of sarcoma 180, adenocarcinoma E 0771, and adenocarcinoma 755 tumors and reduces the size of leukemia L1210 subcutaneous growths in mice. It also decreases delayed-type hypersensitivity and thyroid inflammation in a guinea pig model of thyroiditis when administered pre- or post-disease onset. Formulations containing mercaptopurine have been used for maintenance therapy in patients with acute lymphoblastic leukemia.